Literature DB >> 11034633

The role of brachytherapy for palliation.

D Shasha1, L B Harrison.   

Abstract

The goal of palliative radiation is to alleviate symptoms in a short amount of time and maintain an optimal functional and quality-of-life level while minimizing toxicity and patient inconvenience. Despite advances in multimodality antineoplastic therapies, failure to control the tumor at its primary site frustratingly remains the predominant source of morbidity and mortality in many patients with cancer. Escalation of doses of radiation using external beam irradiation has been shown to improve local tumor control, but limits are imposed by the tolerance of normal surrounding structures. The highly conformal nature of brachytherapy enables the radiation oncologist to accomplish safe escalation of radiation doses to the tumor while minimizing doses to normal surrounding structures. Thus, by enhancing the potential for local control, brachytherapy used alone or as a supplement to external beam radiation therapy retains a significant and important role in achieving the goals of palliation. Proper patient selection, excellent technique, and adherence to implant rules will minimize the risk of complications. The advantages realized with the use of brachytherapy include good patient tolerance, short treatment time, and high rates of sustained palliation. This article reviews various aspects of palliative brachytherapy, including patient selection criteria, implant techniques, treatment planning, dose and fractionation schedules, results, and complications of treatment. Tumors of the head and neck, trachea and bronchi, esophagus, biliary tract, and brain, all in which local failure represents the predominant cause of morbidity and mortality, are highlighted. Copyright 2000 by W.B. Saunders Company.

Entities:  

Mesh:

Year:  2000        PMID: 11034633     DOI: 10.1053/srao.2000.6723

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  1 in total

1.  High-dose-rate brachytherapy for previously irradiated patients with recurrent esophageal cancer.

Authors:  Takeshi Nonoshita; Tomonari Sasaki; Hideki Hirata; Yasushi Toh; Yoshiyuki Shioyama; Katsumasa Nakamura; Hiroshi Honda
Journal:  Radiat Med       Date:  2007-10-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.